Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: A pilot study

Table 1 Characteristics of the patients

10 patients
Age mean 60.20 y.o (range 35-70)
Sex: Male/Female 7/3
Child-Pugh's stage: A,B/C 8/2
"Virus: HBsAg/anti-HCV 8/2"

Table 2 Main clinical side effects observed during the treatment (n represents the number of patients having experienced the effect in any of the courses)

	Grade of toxicity
	1	2	3	4
Oral dryness	3	1	0	0
Diarrhea	1	2	0	0
Vomiting	1	0	0	0
Liver dysfunction	1	2	0	0
Fever	0	0	0	0
Hair loss	1	0	0	0
BM suppression	4	4	0	0